Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Prostate Cancer”

863 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 863 results

Testing effectiveness (Phase 2)Study completedNCT00214097
What this trial is testing

Phase I/II Hypofractionated Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 347
Very early researchStudy completedNCT01434342
What this trial is testing

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Who this might be right for
Lung CancerTobacco Use DisorderBreast Cancer+2 more
Wake Forest University Health Sciences 146
Not applicableLooking for participantsNCT06325046
What this trial is testing

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Mayo Clinic 144
Testing effectiveness (Phase 2)Looking for participantsNCT04989946
What this trial is testing

Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 60
Not applicableStudy completedNCT00176579
What this trial is testing

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Who this might be right for
OsteoporosisProstate Cancer
University of Medicine and Dentistry of New Jersey 27
Testing effectiveness (Phase 2)Ended earlyNCT01913197
What this trial is testing

Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy

Who this might be right for
Prostate Cancer
St. Luke's-Roosevelt Hospital Center 2
Not applicableUnknownNCT04724577
What this trial is testing

12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer

Who this might be right for
RadiotherapyProstate Cancer
Shanghai Proton and Heavy Ion Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Early research (Phase 1)Study completedNCT00005627
What this trial is testing

Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute
Early research (Phase 1)Looking for participantsNCT05656573
What this trial is testing

CART-PSMA Cells for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Nova Therapeutics LLC 20
Testing effectiveness (Phase 2)Study completedNCT00078923
What this trial is testing

Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 32
Early research (Phase 1)Study completedNCT01324583
What this trial is testing

Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 48
Large-scale testing (Phase 3)Study completedNCT03070886
What this trial is testing

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7
NRG Oncology 612
Early research (Phase 1)Active Not RecruitingNCT03873805
What this trial is testing

PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8+2 more
City of Hope Medical Center 14
Early research (Phase 1)Study completedNCT02603965
What this trial is testing

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 25
Early research (Phase 1)Ended earlyNCT05673109
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 8
Large-scale testing (Phase 3)Ended earlyNCT00005075
What this trial is testing

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP Technomed
Load More Results